Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Sandusky, OH -- May 6, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today highlighted that the upcoming CBD Nutraceutical Sales Rollout Presentation scheduled for tomorrow...
Sandusky, OH -- May 5, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today confirmed a CBD Nutraceutical Sales Rollout Presentation scheduled this Friday, May 7, 2021. Last...
Sandusky, OH -- May 3, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today announced plans to present the company’s CBD Nutraceutical Sales Rollout Plan this Friday, May 7...
Sandusky, OH -- April 13, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today released a management update on the company’s ongoing CBD Pharmaceutical Development Program...
April 12, 2021 -- InvestorsHub NewsWire -- via AmericanBulls.com/PAOG PAO Group, Inc. (USOTC: PAOG) Our system’s recommendation today is to BUY...
Sandusky, OH -- April 8, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today announced a management update on the company’s ongoing CBD Pharmaceutical Development Program...
Sandusky, OH -- March 16, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today released details on the company’s nutraceutical developments initiative following last...
Sandusky, OH -- March 10, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (OTC Pink: PAOG) today encouraged all interested to save the date, Tuesday, March 16, 2021, when PAOG will...
Sandusky, OH -- March 8, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today announced initiating the development of its new nutraceutical, RELAX-RX, targeting the anxiety and...
Sandusky, OH -- February 3, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today announced the company anticipates reporting an estimated $50,000 in revenue for Q4 2020. The...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 66192 | 1.0E-6 | CS |
| 4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 145397 | 1.0E-6 | CS |
| 12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 316931 | 1.0E-6 | CS |
| 26 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 229383 | 1.0E-6 | CS |
| 52 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 266828 | 1.07E-6 | CS |
| 156 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 232503 | 3.732E-5 | CS |
| 260 | -0.002999 | -99.9666666667 | 0.003 | 0.017 | 1.0E-6 | 4226076 | 0.00188526 | CS |
| Symbol | Preis | Vol. |
|---|---|---|
| AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0,00275 (0,00%) | 51,06M |
| GTEHGenTech Holdings Inc (CE) | US$ 0,000001 (0,00%) | 48,25M |
| HMBLHUMBL Inc (PK) | US$ 0,0002 (-33,33%) | 42,65M |
| CBGLCannabis Global Inc (PK) | US$ 0,00015 (50,00%) | 41,81M |
| GTVHGolden Triangle Ventures Inc (PK) | US$ 0,0008 (33,33%) | 41,61M |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
